---
title: "European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275785702.md"
description: "European equities traded in the US saw a decline of 1.22% on the S&P Europe Select ADR Index. Notable gainers included Anheuser-Busch InBev (+4.6%) and Criteo (+2.5%), while Nokia (-5.2%) and Sanofi (-4%) led the decliners. In the UK and Ireland, InterContinental Hotels Group (+1.9%) and Pearson (+0.9%) were among the gainers, whereas Biodexa Pharmaceuticals (-9.1%) and Mereo BioPharma Group (-8.3%) faced significant losses. MT Newswires does not provide investment advice."
datetime: "2026-02-12T16:21:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275785702.md)
  - [en](https://longbridge.com/en/news/275785702.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275785702.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275785702.md) | [繁體中文](https://longbridge.com/zh-HK/news/275785702.md)


# European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

11:21 AM EST, 02/12/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 1.22% to 1,824.99 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by brewing company Anheuser-Busch InBev ( BUD ) and internet advertising firm Criteo ( CRTO ) , which rose 4.6% and 2.5% respectively. They were followed by biopharmaceutical company argenx (ARGX) and pharmaceutical company Novo Nordisk ( NVO ) , which were up 1.3% and 0.7% respectively.

The decliners from continental Europe were led by telecommunications company Nokia ( NOK ) and pharmaceutical company Sanofi ( SNY ) , which fell 5.2% and 4% respectively. They were followed by internet browser company Opera (OPRA) and biotech firm Evaxion ( EVAX ) , which were down 3.7% and 3.1% respectively.

From the UK and Ireland, the gainers were led by hospitality company InterContinental Hotels Group ( IHG ) and educational publisher Pearson (PSO), which advanced 1.9% and 0.9% respectively. They were followed by medical device maker Smith & Nephew ( SNN ) and pharmaceutical company Silence Therapeutics ( SLN ) , which increased 0.6% and 0.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Mereo BioPharma Group ( MREO ) , which dropped 9.1% and 8.3% respectively. They were followed by insurance company Prudential (PUK) and biopharmaceutical company and Akari Therapeutics ( AKTX ) , which lost 7.6% and 2.3% respectively.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [Anheuser-Busch InBev SA/NV (BUD.US)](https://longbridge.com/en/quote/BUD.US.md)
- [InterContinental Hotels Group PLC (IHG.US)](https://longbridge.com/en/quote/IHG.US.md)
- [Criteo S.A. (CRTO.US)](https://longbridge.com/en/quote/CRTO.US.md)
- [Mereo BioPharma Group plc (MREO.US)](https://longbridge.com/en/quote/MREO.US.md)
- [Sanofi (SNY.US)](https://longbridge.com/en/quote/SNY.US.md)
- [Biodexa Pharmaceuticals Plc (BDRX.US)](https://longbridge.com/en/quote/BDRX.US.md)
- [Pearson plc (PSO.US)](https://longbridge.com/en/quote/PSO.US.md)
- [Nokia Oyj (NOK.US)](https://longbridge.com/en/quote/NOK.US.md)

## Related News & Research

- [Anheuser-Busch InBev SA/NV (EBR:ABI) Analysts Are Pretty Bullish On The Stock After Recent Results](https://longbridge.com/en/news/275997691.md)
- [AB Inbev CFO Fernando Tennenbaum: 2026 will hopefully be a more normal year on costs, we see further opportunities to expand margin](https://longbridge.com/en/news/275819045.md)
- [Sanofi Says Rilzabrutinib Receives Orphan Drug Status in Japan](https://longbridge.com/en/news/277441717.md)
- [Nokia, UAE's Spark Team Up for Training Programs, Specialized Platform](https://longbridge.com/en/news/277753006.md)
- [Brazil's EMS purchases Sanofi's Medley](https://longbridge.com/en/news/278113014.md)